Acute Kidney Injury in Intensive Care Patients

NCT05970952 | Unknown

• 1 other identifier: 82-2023
• Study Type: observational
• Target: 159
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this prospective observational study is to evaluate the incidence, risk factors, and outcomes for development of acute kidney injury (AKI) in intensive care pateints. The main questions it aims to answer are:

• What is the incidence of acute kidney injury in intensive care patients?
• What are risk factors for development of acute kidney injury? All adult patients admitted to the ICU with a stay of 48 h or more will be included in the study.

Conditions

Acute Renal Injury; Critical Illness

Keywords

acute renal injury; intensive care unit

Outcome Measures

Primary Outcomes (1)

• To assess the incidence of acute kidney injury in ICU patients

  During their management lasting more than 48 hours in the ICU, some patients develop acute kidney injury.

  Up to 28 day

Eligibility Criteria

• Age: 18 Years - 100 Years
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Probability Sample

Study Population

The patients who developed acute kidney inhury during intensive care unit stay.

You may qualify if:

• All adult patients admitted to the ICU with a stay of 48 h or more

You may not qualify if:

• Patients with missing data, end-stage renal disease, existence of AKI at the time of ICU admission or history of renal transplantation will be excluded from the study. Patients that were readmitted to the ICU within 48 h will reunited with the first admission and be considered as one admission for the analysis.

Sponsors & Collaborators

• Haseki Training and Research Hospital: lead

Study Sites (1)

Health Science University, Haseki Training and Research Hospital

Istanbul, Turkey (Türkiye)

RECRUITING

MeSH Terms

Conditions

Acute Kidney Injury; Critical Illness

Condition Hierarchy (Ancestors)

Renal Insufficiency; Kidney Diseases; Urologic Diseases; Female Urogenital Diseases; Female Urogenital Diseases and Pregnancy Complications; Urogenital Diseases; Male Urogenital Diseases; Disease Attributes; Pathologic Processes; Pathological Conditions, Signs and Symptoms

Study Officials

• Sinan Uzman, Assoc. prof.

  Health Science Unibersity, Haseki Training and Research Hospital

  STUDY DIRECTOR

Central Study Contacts

Sinan Uzman, Assoc. prof.

CONTACT

+905055645271; drsinanuzman@yahoo.com

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: July 24, 2023
• First Posted: August 2, 2023
• Study Start: May 1, 2023
• Primary Completion: October 24, 2023
• Study Completion: November 24, 2023
• Last Updated: August 2, 2023

Record last verified: 2023-07

Locations

TU (1)